当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第26期
编号:13107585
小剂量辛伐他汀对心肾综合征患者补体水平及补体受体表达的影响(4)
http://www.100md.com 2017年9月15日 《中国医药导报》 2017年第26期
     [20] Ghebrehiwet B. The complement system:an evolution in progress [J]. F1000Res,2016,5:2840.

    [21] Clark DJ,Cleman MW,Pfau SE,et al. Serum complement activation in congestive heart failure [J]. Am Heart J,2001,141(4):684-690.

    [22] Hovland A,Jonasson L,Garred P,et al. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis [J]. Atherosclerosis,2015,241(2):480-494.

    [23] Farrar CA,Zhou W,Lin T,et al. Local extravascular pool of C3 is a determinant of postischemic acute renal failure [J]. FASEB J,2006,20:217-226.

    [24] Kelly KJ,Liu Y,Zhang J,et al. Renal C3 complement component:feed forward to diabetic kidney disease [J]. Am J Nephrol,2015,41(1):48-56.

    [25] Java A,Liszewski MK,Hourcade DE,et al. Role of complement receptor1(CR1;CD35)on epithelial cells:a model for understanding complement-mediated damage in the kidney [J]. Mol Immunol,2015,67(200):584-595.

    (收稿日期:2017-05-16 本文編辑:李亚聪), http://www.100md.com(王治 黄进 李益民 严雪娇)
上一页1 2 3 4